← FDA Drug Approvals (Drugs@FDA)

EPHEDRINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2025-03-11

Drug application

FDA Application #

ANDA218271

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPHEDRINE SULFATE

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2025-03-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown